Sarah Gorey
@sarahgorey.bsky.social
58 followers
50 following
6 posts
👩🏻⚕️ Geriatric Medicine Fellow 🇮🇪 in 🇺🇸, 🧠Stroke Research & PhD candidate UCD Dublin, 💻MSc NUIG Galway, YSPR committee European Stroke Organisation 🇪🇺
Posts
Media
Videos
Starter Packs
Reposted by Sarah Gorey
Sarah Gorey
@sarahgorey.bsky.social
· Sep 4
Reposted by Sarah Gorey
Reposted by Sarah Gorey
Reposted by Sarah Gorey
Reposted by Sarah Gorey
Sarah Gorey
@sarahgorey.bsky.social
· May 28
The latest Stats, STAT! animated video from NEJM Evidence describes the use of restricted mean survival time in survival analysis when the proportional hazards assumption is not met.
📺 Full video and transcript: eviden.cc/42YS8FQ
#StatsSky #Statistics
📺 Full video and transcript: eviden.cc/42YS8FQ
#StatsSky #Statistics
Reposted by Sarah Gorey
Chris Kotanidis
@cpkotanidis.bsky.social
· Apr 22
Coronary inflammation and cardiovascular risk in breast cancer after radiotherapy
Radiotherapy (RT) is known to reduce the rate of disease recurrence following breast-conserving surgery in patients with breast cancer, but also entails ir
academic.oup.com
Reposted by Sarah Gorey
Reposted by Sarah Gorey
1/ 🚨 NEW #5Pearls: Lp(a) and ASCVD Risk
Lp(a) is a lipoprotein similar to LDL but a different entity!
Lp(a) has important implications for cardiovascular disease ‼️
🖥️: coreimpodcast.com/2025/04/02/lpa…
Sponsor: Freed AI
Lp(a) is a lipoprotein similar to LDL but a different entity!
Lp(a) has important implications for cardiovascular disease ‼️
🖥️: coreimpodcast.com/2025/04/02/lpa…
Sponsor: Freed AI
Reposted by Sarah Gorey
Sarah Gorey
@sarahgorey.bsky.social
· Mar 5
1/ 🚨 NEW #BeyondJournalClub w/ @NEJMGroup: The APACHE Study ⤵️
We gave a sneak peak the other day, but now let’s dive into it 🌊
🖥️: coreimpodcast.com/2025/03/05/mic…
We gave a sneak peak the other day, but now let’s dive into it 🌊
🖥️: coreimpodcast.com/2025/03/05/mic…
Reposted by Sarah Gorey
The Lancet
@thelancet.com
· Feb 25
PEPFAR under review: what's at stake for PEPFAR's future
The US President's Emergency Plan for AIDS Relief (PEPFAR) faces a pivotal moment,
confronting one of its most challenging periods since its launch in 2003. The new
policy priorities of the administra...
tinyurl.com